Jaglal Susan B, Weller Iris, Mamdani Muhammad, Hawker Gillian, Kreder Hans, Jaakkimainen Liisa, Adachi Jonathan D
Department of Rehabilitation Science, University of Toronto, Toronto, Canada.
J Bone Miner Res. 2005 Jun;20(6):898-905. doi: 10.1359/JBMR.041231. Epub 2004 Dec 20.
A worldwide epidemic of hip fractures has been predicted. Time trends in BMD testing, bone-sparing medications and hip and wrist fractures in the province of Ontario, Canada, were examined. From 1996 to 2001, BMD testing and use of bone-sparing medications increased each year, whereas despite the aging of the population, wrist and hip fracture rates decreased.
If patients with osteoporosis are being diagnosed and effective treatments used with increasing frequency in the population, rates of hip and wrist fractures will remain stable or possibly decrease. We report here time trends in BMD testing, prescriptions for bone-sparing medications, hip and wrist fracture rates, and population projections of fracture rates to 2005 in the province of Ontario, Canada.
Ontario residents have universal access to Medicare. To examine time trends in BMD testing, all physician claims for DXA from 1992 to 2001 were selected from the Ontario Health Insurance Plan (OHIP) database. Trends in prescribing were examined from 1996 to 2003 using data from the Ontario Drug Benefit plan, which provides coverage to persons > or = 65 years of age. Actual numbers of hip and wrist fractures were determined for 1992-2000 and population projections for 2001-2005 using time-series analysis. Wrist fractures were identified in the OHIP database and hip fractures through hospital discharge abstracts.
From 1992 to 2001, the number of BMD tests increased 10-fold. There has been a steady increase in the number of persons filling prescriptions for antiresorptives (12,298 in 1996 to 225,580 in 2003) and the majority were for etidronate. For women, the rate of decline for wrist fractures is greater than that for hip fractures. The rate of hip fracture was fairly constant around 41 per 10,000 women > or = 50 years between 1992 and 1996. In 1997, the hip fracture rate began to decrease, and the population projections suggest that this downward trend will continue to a rate of 33.1 per 10,000 in 2005.
Our findings suggest that fracture rates may be on the decline, despite the aging of the population, because of increased patterns of diagnosis and treatment for osteoporosis.
预计全球将出现髋部骨折的流行趋势。对加拿大安大略省骨密度检测、保骨药物以及髋部和腕部骨折的时间趋势进行了研究。1996年至2001年期间,骨密度检测及保骨药物的使用逐年增加,然而尽管人口老龄化,腕部和髋部骨折率却有所下降。
如果骨质疏松症患者的诊断率和有效治疗的使用率在人群中不断提高,髋部和腕部骨折率将保持稳定甚至可能下降。我们在此报告加拿大安大略省骨密度检测、保骨药物处方、髋部和腕部骨折率的时间趋势,以及到2005年骨折率的人口预测情况。
安大略省居民均可享受医疗保险。为研究骨密度检测的时间趋势,从安大略省医疗保险计划(OHIP)数据库中选取了1992年至2001年所有医生开具的双能X线吸收法(DXA)检测申请。利用安大略省药物福利计划的数据研究1996年至2003年的处方趋势,该计划为65岁及以上人群提供保险。采用时间序列分析确定1992 - 2000年髋部和腕部骨折的实际数量以及2001 - 2005年的人口预测。在OHIP数据库中识别腕部骨折,通过医院出院摘要识别髋部骨折。
1992年至2001年期间,骨密度检测数量增加了10倍。开具抗吸收药物处方的人数稳步增加(从1996年的12298人增加到2003年的225580人),且大多数为依替膦酸盐。对于女性而言,腕部骨折的下降速率大于髋部骨折。1992年至1996年期间,每10000名50岁及以上女性的髋部骨折率相当稳定,约为41例。1997年,髋部骨折率开始下降,人口预测表明这种下降趋势将持续到2005年,降至每10000人33.1例。
我们的研究结果表明,尽管人口老龄化,但由于骨质疏松症诊断和治疗模式的增加,骨折率可能正在下降。